This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An Australian biotechnology company is building what could be the first AI-driven hospital in Vietnam. As part of its foundational EMR system, the hospital will leverage "advanced AI to collect and analyse patient healthdata, delivering actionable insights for preventive screenings and personalized medical guidance."
International collaboration through the sharing of healthdata is crucial for advancing human health. In particular, as countries increasingly have begun to recognize healthdata as a vital national resource, the impulse to protect such data has risen as well. citizens’ healthdata with China.
By Enrique Santamaría Together with the Data Governance Act (DGA) and the General Data Protection Regulation (GDPR), the proposal for a Regulation on the European HealthData Space (EHDS) will most likely form the new regulatory and governance framework for the use of healthdata in the European Union.
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. to advance research and increase equitable access to clinical trials by contributing de-identified data to the LHN. A Comprehensive Multiomics Platform for the Early Detection of Cancer.
The Company will also expand upon its established artificial intelligence (AI) capabilities with a particular focus on its pioneering use of natural language processing (NLP) to extract insights from unstructured text data in electronic health record (EHR) notes. Expansion Plans.
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The fragmentation of healthdata" , Travis May, Medium, July 31, 2018.
She previously served as a Research Fellow in Medicine, Artificial Intelligence, and Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for the Project on Precision Medicine, Artificial Intelligence, and the Law ( PMAIL ).
By regularly tracking their own healthdata, individuals are more likely to notice trends or changes that could indicate an underlying health issue. With advancements in genomics, biotechnology, and robotics, the potential to revolutionize medicine is enormous.
Namely, legal protections concerning personal healthdata may not apply when the entity offering the service is decidedly not a “provider.” To illustrate the issue, consider that the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA) expressly covers genetic information as a form of healthdata.
What You Should Know: Gero , a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence.
Examples include the development and deployment of COVID-19 screening and triage bots, mobile apps for field workers, dashboards and analytics for public health agencies, and migrations to Azure to enable population healthdata management.
In Mexico, Omica.bio is leading a revolution in ethical biotechnology. Through its network of community-driven biobanks, they partner with underserved communities and unique patient cohorts to provide global researchers with diverse health-related datasets.
On top of that a firm will -in the near future- need to comply with all the specific requirements for ‘high risk’ AI technology as stipulated in the Proposal for a Regulatory Framework for Artificial Intelligence (EU AI Act), and navigate its way through the future European HealthData Space.
With different entities potentially using organoids to generate donor-specific, if not donor-relevant healthdata, we will almost certainly run into obstacles in privacy and informed consent. New Legal Questions for Organoids first appeared on Bill of Health. The post R&D Mini-Me?
Millenson The latest draft government strategic plan for health information technology pledges to support health information sharing among individuals, health care providers and others “so that they can make informed decisions and create better health outcomes.”
Additionally, it is yet to be determined how the new AI Act will synchronize with other legislative proposals like the European HealthData Space (EHDS) , and existing EU regulations such as the General Data Protection Regulation (GDPR) and the Medical Device Regulation (MDR).
The EO lists biotechnology on its list of examples of “pressing security risks,” and the Secretary of Commerce is charged with enforcing detailed reporting requirements for AI use (with guidance from the National Institute of Standards and Technology) in developing biological outputs that could create security risks.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content